[(2R)-1-[(2S)-2-Amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid mesylate – (150080-09-4)

SGC-CBP30, 1613695-14-9, (s)-4-(1-(2-(3-chloro-4-methoxyphenethyl)-5-(3, 5-dimethylisoxazol-4-yl)-1h-benzo[d]imidazol-1-yl)propan-2-yl)morpholine, 2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(dimethyl-1, 2-oxazol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1, 3-benzodiazole, 2-[2-(3-Chloro-4-Methoxyphenyl)ethyl]-5-(3, 5-Dimethyl-1, 2-Oxazol-4-Yl)-1-[(2s)-2-(Morpholin-4-Yl)propyl]-1h-Benzimidazole, 4-[(2S)-1-[2-[2-(3-chloro-4-methoxyphenyl)ethyl]-5-(3, 5-dimethyl-1, 2-oxazol-4-yl)benzimidazol-1-yl]propan-2-yl]morpholine, CBP30, 2-(2-(3-chloro-4-methoxyphenyl)ethyl)-5-(dimethyl-1, 2-oxazol-4-yl)-1-((2S)-2-(morpholin-4-yl)propyl)-1H-1, 3-benzodiazole, 2LO, MFCD26792586, GTPL7529, CHEMBL3622373, SCHEMBL17512896, BDBM188519, GLXC-03977, EX-A2159, NPC69514, s7256, AKOS024458401, CCG-269770, NCGC00351475-07, SGC-CBP30, >=98% (HPLC), AC-35767, AS-56079, BP-25374, HY-15826, SW219645-1, BRD-K24821794-001-01-4, Q27088793, 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3, 5-dimethyl-1, 2-oxaZol-4-yl)-1-[(2S)-2-(morpholin-4-yl)propyl]-1H-1, 3-benZodiaZole, 2-[2-(3-Chloro-4-methoxyphenyl)ethyl]-5-(3, 5-dimethyl-4-isoxazolyl)-1-[(2S)-2-(4-morpholinyl)propyl]-1H-benzimidazole CBP 30 SGC-CBP 30